| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/16/2005 | US6930102 16-halogen-epothilone derivatives, process for their production, and their pharmaceutical use |
| 08/16/2005 | US6930101 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/16/2005 | US6930100 Phosphate prodrugs of fluoroxindoles |
| 08/16/2005 | US6930099 Antiinflammatory mixtures comprising; acetylsalicylic acid, an amino sugar selected from glucosamine, glucosamine hydrochloride, glucosamine sulfate, N-acetylglucosamine, and zinc sulfate, or zinc chloride; hypotensive agents |
| 08/16/2005 | US6930098 Polysulphated cyclodextrins or addition salts thereof in obtaining pharmaceutical compositions for use in the treatment of arthrosis. |
| 08/16/2005 | US6930097 Matrix metalloproteinase and tumor necrosis factor inhibitors |
| 08/16/2005 | US6930096 Administering to a subject before the onset of an ischemic episode at daily dosages of 1-2 g of free cdp-choline |
| 08/16/2005 | US6930093 [1- beta -D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide,] 1- beta -L-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide, [1- beta -ribofuranosyl-1H-1,2,4-triazole-3-amidine,] 1- beta -L-ribofuranosyl-1H-1,2,4-triazole-3-amidine |
| 08/16/2005 | US6930092 Antibiotic agents |
| 08/16/2005 | US6929955 Interactive system for presenting and eliminating substances |
| 08/16/2005 | US6929954 Method for producing purified hematinic iron-saccharidic complex and product produced |
| 08/16/2005 | US6929818 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 08/16/2005 | US6929817 Slowly digestible starch product |
| 08/16/2005 | US6929811 Active agent is selected from the group consisting of anabasine, anatabine, nomicotine, Yerbamate (Ilex paraguariensis) extract, and a liquid extract of tobacco; especially for treating psychological disorders |
| 08/16/2005 | US6929808 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein |
| 08/16/2005 | US6929807 Compositions of plant carbohydrates as dietary supplements |
| 08/16/2005 | US6929805 For oral administration comprising an analgesic with rapid onset of action and at least one systemically acting analgesic with sustained action, such as a combination of benzocaine and acetylsalicylic acid (ASA) |
| 08/16/2005 | US6929802 Method of cancer treatment |
| 08/16/2005 | US6929801 Antiparkinson agent, dermal penetration enhancer of a safe skin-tolerant sunscreen ester and a volatile liquid |
| 08/16/2005 | US6929797 Targeted therapeutic delivery of vitamin D compounds |
| 08/16/2005 | US6929794 IL-12 as an adjuvant for Bordetella pertussis vaccines |
| 08/16/2005 | US6929793 Nutritional composition for treating an immune condition |
| 08/16/2005 | US6929790 Containing a zinc compound containing free available zinc ion and at least one stabilized oxidation potential raising compound, stored separately and mixed prior to using the oral composition. |
| 08/16/2005 | US6929012 Process for the isolation of a major harmful oxidant from cigarette smoke |
| 08/16/2005 | CA2355293C Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 08/16/2005 | CA2347588C An oxazinone used in preparing taxol and process for preparation thereof |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/16/2005 | CA2337046C Sustained release pharmaceutical preparation |
| 08/16/2005 | CA2335363C Adhesively applied external nasal strips and dilators containing medications and fragrances |
| 08/16/2005 | CA2334344C Method and composition for the treatment of epidermal irritations and infections |
| 08/16/2005 | CA2323707C New substances derived from benzothiophenes, benzofurans and indolics, processes for preparing them and pharmaceutical compounds containing them |
| 08/16/2005 | CA2323703C New cyano-indole serotonin reuptake inhibitors, the procedure for preparing them and the pharmaceutical formulations that contain them |
| 08/16/2005 | CA2280985C Compound containing urea and use of the compound in the field of cosmetics and/or dermatology |
| 08/16/2005 | CA2273094C Gel formulations for topical drug delivery |
| 08/16/2005 | CA2252900C Cosmetic composition for rejuvenation of skin without skin irritation |
| 08/16/2005 | CA2238521C Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
| 08/16/2005 | CA2220438C (n-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
| 08/16/2005 | CA2206566C Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds |
| 08/16/2005 | CA2166059C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/16/2005 | CA2165945C Cleaning and disinfecting formulations |
| 08/16/2005 | CA2131350C Sustained release drug formulation containing a tramadol salt |
| 08/16/2005 | CA2106642C Carbazolone derivatives and process for preparing the same |
| 08/16/2005 | CA2098533C Carrier system against gnrh |
| 08/16/2005 | CA2094859C Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| 08/16/2005 | CA2084075C The ciliary neurotrophic factor receptor |
| 08/16/2005 | CA2078221C Pharmaceutical compositions comprising taurolidine and/or taurultam |
| 08/11/2005 | WO2005073398A1 Method of assaying capability of inhibiting fat level increase |
| 08/11/2005 | WO2005073240A2 Novel hiv protease inhibitors |
| 08/11/2005 | WO2005073238A1 Pyridobenzoxazine derivative |
| 08/11/2005 | WO2005073237A2 Polymorphic forms of a gabaa agonist |
| 08/11/2005 | WO2005073236A2 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors |
| 08/11/2005 | WO2005073230A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments |
| 08/11/2005 | WO2005073224A2 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer |
| 08/11/2005 | WO2005073221A1 HETEROCYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 08/11/2005 | WO2005073220A1 Remedy for irritable bowel syndrome with diarrhea |
| 08/11/2005 | WO2005073218A1 Therapeutic agent for vasospasm accompanying bypass operation |
| 08/11/2005 | WO2005073214A2 Novel inhibitors of chymase |
| 08/11/2005 | WO2005073203A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 08/11/2005 | WO2005073200A1 Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 08/11/2005 | WO2005073199A1 Indazole derivatives as inhibitors of hormone-sensitive lipases |
| 08/11/2005 | WO2005073198A1 Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole |
| 08/11/2005 | WO2005073193A1 Vanilloid receptor ligands and their use in treatments |
| 08/11/2005 | WO2005073192A1 Novel piperidines as chemokine modulators (ccr) |
| 08/11/2005 | WO2005073190A1 Selective estrogen receptor modulators |
| 08/11/2005 | WO2005073186A1 Pyrrolidine derivatives |
| 08/11/2005 | WO2005073183A1 Aryl sulfide derivative |
| 08/11/2005 | WO2005073154A1 A method of extracting totarol and/or a product containing totarol |
| 08/11/2005 | WO2005072893A1 Functionalized colloidal metal compositions and methods |
| 08/11/2005 | WO2005072826A2 Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection |
| 08/11/2005 | WO2005072779A2 Growth factor-binding compounds attached to a calixarene |
| 08/11/2005 | WO2005072775A1 Anti-inflammatory analgesic for external use |
| 08/11/2005 | WO2005072774A1 Vaginal compositions for treating infections |
| 08/11/2005 | WO2005072773A1 Erythrocyte function modifying substance |
| 08/11/2005 | WO2005072771A1 Neuroprotective complex for treatment of cerebral ischemia and injury |
| 08/11/2005 | WO2005072763A1 Liver fibrosis inhibitor |
| 08/11/2005 | WO2005072762A1 Compositions enriched in phenolic compounds and methods for producing the same |
| 08/11/2005 | WO2005072761A1 Compositions and methods for reducing cholesterol comprising guggul and beta-glucan and/or plant sterols |
| 08/11/2005 | WO2005072760A1 Polyphenols as an intravesical agent for the prevention of transitional cell tumor implantation |
| 08/11/2005 | WO2005072752A1 Preventive or therapeutic agents for hyperphosphatemia |
| 08/11/2005 | WO2005072751A1 Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis |
| 08/11/2005 | WO2005072750A1 Composition for inhibting dietary lipid absorption |
| 08/11/2005 | WO2005072749A1 Compositions and methods for homocsyteine regulation |
| 08/11/2005 | WO2005072748A1 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis |
| 08/11/2005 | WO2005072747A1 Bone resorption inhibitors |
| 08/11/2005 | WO2005072746A1 P2x receptor inhibitor |
| 08/11/2005 | WO2005072745A2 Aqueous solutions comprising prednisolone and a cyclodextrin derivative |
| 08/11/2005 | WO2005072744A1 Vitreous-visualizing agents |
| 08/11/2005 | WO2005072743A1 Bronchodilators |
| 08/11/2005 | WO2005072742A1 Treatment of psychoses with quetiapine antipsychotic |
| 08/11/2005 | WO2005072741A1 ((11-oxo-10,11-dihydrodibenzo [b, f] [1, 4] oxazepin-1-yl)oxy) acetic acid derivatives and related compounds as cardiovascular preparations used to treat arteriolosclerosis |
| 08/11/2005 | WO2005072740A2 Anorectic compounds |
| 08/11/2005 | WO2005072739A1 Drug for treating migraine |
| 08/11/2005 | WO2005072738A1 Compositions useful especially for treatment or prevention of metabolic syndrome |
| 08/11/2005 | WO2005072737A1 Injectable euthanasia compositions that include a taste aversive agent |
| 08/11/2005 | WO2005072736A2 Stable gabapentin compositions |
| 08/11/2005 | WO2005072735A1 Piperidinyl prostaglandin e analogs |
| 08/11/2005 | WO2005072734A1 Pharmaceutical composition for promoting angiogenesis |
| 08/11/2005 | WO2005072732A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 08/11/2005 | WO2005072730A1 Therapeutic agent for diarrhea-type irritable bowel syndrome |
| 08/11/2005 | WO2005072729A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |